https://www.selleckchem.com/pr....oducts/adaptaquin.ht
There are 46 patients in insulin resistance group (76.7%) developed antiplatelet drug resistance, which was significantly more frequent than patients without insulin resistance (35%, P less then 0.0001). Insulin resistance was an independent risk factor for antiplatelet drug resistance in patients with recent ischemic stroke/TIA after adjusted for confounding factors (Odds Ratio 5.281; 95%CI, 2.15 to 13.01, P less then 0.0001).Conclusions Insulin resistance was an independent predictor for development of antiplatelet drug resistance
Like
Comment
Share
